Role of hepatitis B virus in non-B, non-C chronic liver disease: In vitro proliferation and interferon-γ production of peripheral blood mononuclear cells in response to hepatitis B core antigen and its relation to hepatitis activity

American Journal of Gastroenterology

Volumn 95, Issue 1, 2000, Pages 239-247

  Niigaki, Misa ^a   Fukuda, Ryo ^a   Hamamoto, Sachiko ^a   Ishimura, Norihisa ^a   Ishihara, Shunji ^a   Akagi, Shuji ^a   Watanabe, Makoto ^a   Kinoshita, Yoshikazu ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; VIRUS DNA;

ADULT; ARTICLE; CELL PROLIFERATION; CHRONIC LIVER DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; SEROLOGY; VIRUS PATHOGENESIS;

ADULT; AGED; DNA, VIRAL; FEMALE; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS, CHRONIC; HEPATITIS, VIRAL, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON TYPE II; LEUKOCYTES, MONONUCLEAR; LIVER; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION;

EID: 0033985992     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00709-1     Document Type: Article

References (42)

1. Michalak T., Pasquinelli C., Guilhot S., et al. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest. 93:1994;230-239.
2. Penna A., Artini M., Cavalli A., et al. Long-lasting memory T cell responses following self-limiting acute hepatitis B. J Clin Invest. 98:1996;1185-1194.
3. Rehermann B., Ferrari C., Pasquinelli C., et al. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nature Med. 2:1996;1104-1108.
4. Brechot C., Degos F., Lugassy C., et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med. 312:1985;270-276.
5. Lai M.-Y., Chen P.-J., Yang P.-M., et al. Identification and characterization of intrahepatic hepatitis B virus DNA in HBsAg-seronegative patients with chronic liver disease and hepatocellular carcinoma in Taiwan. Hepatology. 12:1990;575-581.
6. Liang T.J., Baruch Y., Ben-Porath E., et al. Hepatitis B virus infection in patients with idiopathic liver disease. Hepatology. 13:1991;1044-1051.
7. Uchida T., Shimojima M., Gotoh K., et al. "Silent" hepatitis virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis. Microbiol Immunol. 38:1994;281-283.
8. Feitelson M.A., Duan L.X., Guo J., et al. X region deletion variants of hepatitis B virus in surface antigen-negative infections and non-A, non-B hepatitis. J Infect Dis. 172:1995;713-722.
9. Fukuda R., Ishimura N., Kushiyama Y., et al. Hepatitis B virus with X gene mutation is responsible for the majority of serologically "silent" non-B, non-C chronic hepatitis. Microbiol Immunol. 40:1996;481-488.
10. Naoumov N.V., Eddlestone A.L.W.F. Host immune response and variations in the virus genome Pathogenesis of liver damage caused by hepatitis B virus . Gut. 35:1994;1013-1017.
11. Mondelli M., Mieli-Vergani G., Alberti A., et al. Specificity of T lymphocyte cytotoxity to autologous hepatocytes in chronic hepatitis B virus infection Evidence that T cells are directed against HBV core antigen expressed on hepatocytes . J Immunol. 128:1982;2773-2777.
12. Milich D.R., MacLachlan A., Moriarty A., et al. Immune response to hepatitis B core antigen (HBcAg) Localization of T cell recognition site within HBcAg/HBeAg . J Immunol. 139:1987;1223-1227.
13. Sylvan S.P.E., Hellstrom U.B., Flehming B. Characterization of cell mediated immune response to the hepatitis B core protein in man. Clin Exp Immunol. 68:1987;233-241.
14. Inoue M., Kakumu S., Yoshioka K., et al. Hepatitis B core antigen-specific IFN-γ production of peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. J Immunol. 142:1989;4006-4011.
15. Ferrari C., Penna A., Bertoletti A., et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B. J Immunol. 145:1990;3442-3449.
16. Al-Wabel A., Al-Janadi M., Raziuddin S. Cytokine profile of viral and autoimmune chronic active hepatitis. J Allergy Clin Immunol. 92:1993;902-908.
17. Tsai S.L., Huang S.N. T cell mechanisms in the immunopathogenesis of viral hepatitis B and C. J Gastroenterol Hepatol. 12:(suppl):1997;S227-SS35.
18. Tsai S.L., Chen P.J., Lai M.Y., et al. Acute exacerbation of chronic hepatitis type B are accompanied by increased T cell response to hepatitis B core and e antigens. J Clin Invest. 89:1992;87-96.
19. Ishikawa T., Kakumu S., Yoshioka K., et al. Immune response of peripheral blood mononuclear cells to antigen determinants within hepatitis B core antigen in HB virus-infected man. Liver. 12:1992;100-105.
20. Marinos G., Torre F., Chokshi S., et al. Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B A major factor in activation of the host immune response to hepatitis B virus . Hepatology. 22:1995;1044-1049.
21. Scotte J., Hadchouel M., Hery C., et al. Detection of hepatitis B virus in serum by a simple spot hybridization technique Comparison with results for other viral markers . Hepatology. 3:1983;279-284.
22. Okamoto H., Okada S., Sugiyama Y., et al. Detection of hepatitis C virus by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5′-non coding region. Jpn J Exp Med. 60:1990;215-222.
23. Javis L.M., Davidson F., Halney J.P., et al. Infection with hepatitis G virus among recipient of plasma products. Lancet. 348:1996;1352-1355.
24. Knodell R.G., Ishak K.G., Black W.C., et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1:1981;431-435.
25. Jung M., Spengler U., Schraut W., et al. Hepatitis B virus antigen-specific T cell activation in patients with acute and chronic hepatitis B. J Hepatol. 13:1991;310-317.
26. Wakita T., Kakumu S., Yoshioka K., et al. Cellular immune response of peripheral blood nomonuclear cells to HBV antigens during acute and chronic HBV infection. Digestion. 52:1992;26-33.
27. Fukuda R., Nguyen X.T., Ishimura N., et al. X gene and precore region mutations in the hepatitis B virus genome in person positive for antibody to hepatitis B e antigen Comparison between asymtomatic "healthy" carriers and patients with severe chronic active hepatitis . J Infect Dis. 172:1995;1191-1197.
28. Spandau D.F., Lee C.H. Trans-activation of viral enhancers by the hepatitis B virus X protein. J Virol. 62:1988;427-434.
29. Unger T., Shaul Y. The X protein of the hepatitis B virus acts as a transcriptional factor when targeted to its responsive elements. EMBO J. 9:1990;1889-1895.
30. Maguire H.F., Hoeffler J.P., Siddiqui A. HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions. Science. 252:1990;842-844.
31. Aufiero B., Schneider J. The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters. EMBO J. 9:1990;497-504.
32. Rossner M.T. Review Hepatitis B virus X-gene product: A promiscuous transcriptional activator . J Med Virol. 36:1992;101-107.
33. Ritter S.E., Whitten T.M., Quets A.T., et al. An internal domain of the hepatitis B virus X antigen is necessary for transactivity. Virology. 182:1991;841-845.
34. Chen H.S., Kaneko S., Gironews R., et al. The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol. 67:1993;1218-1226.
35. Zoulim F., Saputelli J., Seeger C. Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol. 68:1994;2026-2030.
36. Kremsdorf D., Garreau F., Duclos H., et al. Complete nucleotide sequence and viral envelope protein expression of a hepatitis B virus DNA derived from a hepatitis B surface antigen-seronegative patients. J Hepatol. 18:1993;244-250.
37. Kato J., Hasegawa H., Torii N., et al. A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B. Hepatology. 23:1996;389-395.
38. Deursen F.J., Hino K., Wyatt D., et al. Use of PCR in resolving diagnostic difficulties potentially caused by genetic variation of hepatitis B virus. J Clin Pathol. 51:1998;149-153.
39. Chung H.T., Lee J.S.K., Lok A.S.F. Prevention of post-transfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg. Hepatology. 18:1993;1045-1049.
40. Chung H.T., Lai C.L., Lok A.S.F. Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis. Hepatology. 22:1995;25-29.
41. Uchida T., Shimojima S., Gotoh K., et al. Pathology of liver infected with "silent" hepatitis B virus mutant. Liver. 14:1994;251-256.
42. Kanai K., Kako M., Hino K., et al. Core promoter mutations hepatitis B virus for the response to interferon in e antigen-positive chronic hepatitis B. Am J Gastroenterol. 91:1996;2150-2156.